All FDA articles
-
OpinionCatch-22: the FDA, probiotics, and preterm infants
As the FDA issues warning letters about probiotic products sold for use in hospitalized preterm infants, families of babies threatened by necrotizing enterocolitis (NEC) now face a deadly Catch-22 situation.
-
NewsVaccine created to prevent dangerous tropical disease receives FDA approval
The US Food and Drug Administration (FDA) has approved the world’s first vaccine against the chikungunya virus – Ixchiq.
-
NewsVaccine for Lyme disease one step closer with promising six-month results
A vaccine for Lyme disease is one step closer after Pfizer Inc and Valneva SE reported positive results in their antibody persistence data six months after completing a three-dose or two-dose schdule in children and adults with vaccine candidate VLA15.